Skip to main content
Global Pediatric Health logoLink to Global Pediatric Health
. 2021 Sep 7;8:2333794X211044114. doi: 10.1177/2333794X211044114

Cardiac Complications Caused by Respiratory Syncytial Virus Infection: Questionnaire Survey and a Literature Review

Hisashi Kawashima 1,, Natsuko Inagaki 2, Toshihiro Nakayama 1, Shinichiro Morichi 1, Shigeo Nishimata 1, Gaku Yamanaka 1, Yasuyo Kashiwagi 1
PMCID: PMC8436282  PMID: 34527765

Abstract

We investigated 22 cases of patients with myocarditis during respiratory syncytial virus (RSV) infection by a questionnaire survey, and performed a literature search to clarify their characteristics. The age distribution was divided into 2 groups, that is, 1 group comprised of patients younger than 4-years old and the other comprised patients older than 15 years. ECG demonstrated disturbance of the conduction system (AV block) in 7 out of 18 patients (38.8%), myocardial damage (ST-T change) in 9 out of 18 patients (50.0%), and tachycardia in 3 out of 18 patients (16.6%). Echocardiography displayed a robust decrease in left-heart function in 12 out of 14 patients. The outcome was 2 deaths, 1 pacemaker placement, 4 patients with mild sequel. Our data suggest that RSV myocarditis caused by RSV infection can be divided into 3 different pathophysiologies, characterized by disturbance of the conduction system, myocardial damage, and increase of autonomy.

Keywords: SIDS, AV block, myocardial damage, tachycardia, NT-pro BNP


Respiratory syncytial virus (RSV) is a worldwide common cause of childhood respiratory infection that can result in death. A report from Taiwan demonstrated that between 2004 and 2007, the annual hospitalization incidence of patients with RSV infection was 1077 and 232 per 100 000 children-years in children under 6 months and under 5 years of age, respectively.1 Fatality during hospitalization for severe RSV infection of the lower respiratory-tract occurs commonly among children especially at higher risk. A systematic review reported that the weighted mean case-fatality rate was 1.2% among preterm infants; 5.2% among children with congenital heart diseases; and 4.1% among children with bronchopulmonary dysplasia. However, the weighted mean case-fatality estimates among children not at high risk was 0.2%.2 An investigation in Japan reported that the reasons for RSV hospitalization in 359 children without underlying diseases were severe bronchiolitis (81.6%), RSV encephalitis (5.3%), near-miss sudden infant death syndrome (SIDS) (3.1%), RSV myocarditis (1.4%), SIDS (0.3%), and others (8.4%).3

Viral infections are considered to be the most common etiology of myocarditis.4 RSV myocarditis has been reported as a cause of viral myocarditis in both the pediatric and adult populations. However, the details of RSV-associated myocarditis have not been clarified to date. Sudden death and similar conditions occur by several pathophysiologies, such as respiratory distress, cardiac problems, and neurological diseases, which are often accompanied with RSV infection. In particular, cardiac manifestations, such as myocarditis, can readily cause fatality in children. In this study, we collected clinical records by questionnaire and reviewed the literature to know the actual situation and their pathophysiology of RSV-associated myocarditis.

Methods

The literature review and the patients collected by questionnaire which was conducted by us3 are shown in Table 1. The literature review are questionnaire was conducted cases with arrhythmia and myocarditis during RSV infection. There were 22 patients (mean and S.D; 10.2 and 18.75 years) without congenital heart disease or serious pulmonary diseases, of which 2 were fatal. The 17 pediatric patients were aged from 1 month to 15 years (average: 2.1-years old), including 10 patients under 1-year old. The sex ratio was 10 boys and 11 girls (1 patient was unknown). Three of the twenty-two patients had underlying diseases (ALL, neonatal HSV infection, and mild Tricuspid regurgitation).

Table 1.

The literature review and the patients collected by questionnaire.

Patient number Age at onset Sex Ethnicity/country Underlying diseases Symptoms Heart rate Respiratory rate Chest X-ray WBC (µL) CRP (mg/dL) CPK (U/L) BNP (pg/mL) Troponin-1 Echocardiography ECG Medication Response Others Report
1 1 month M African American Upper respiratory symptoms, decreased oral intake, nonbilious vomiting Bradycardia Hyperinflation with perihilar atelectasis Increased ESR Not tested EF 33% Ventricular tachyhcardia, PVCs, ST segment elevation Lidocaine, decadron, inderal Good Huang et al5
2 1 month M Japanese Cough, rhinorrhea, decreased feeding 215 60 Normal 7400 0.24 0.15 WNL 2:1 conduction AF Gamma-globulin Good Araki et al6
3 3 months F Hispanic Persistent crying, difficulty breathing, diminished appetite 200 (gallop) 84 (tachypnea) Enlarged heart shadow EF 21% Narrow QRS →AF Lidocaine, amirinone, digoxin, ECMO Good Thomas et al7
4 3 months M Hispanic Fever, cyanosis 300 Cardiomegaly, diffuse patchy lung infiltrate EF 16% Supraventricular tachycardia ATP, dopamine, dobutamine, lidocaine, HFO Motor delay Thomas et al7
5 5 months F Japanese Mild TR Fever, cough, rhinorrhea, tachypnea Abnormal (details unknown) 17 700 1100 46.4 Negative EF 18%, MR ST change Catecolamine Mild decreasing in cardiac function Rapid test Questionnaire
6 7 months F Hispanic None Rhinorrhea, fever, wheezing 200-220 80-90 18 800 0.518 EF 38% Sinus tachycardia Furosemide, incubation, milrinone Good Menchise8
7 8 months F Japanese None Cough, rhinorrhea, decreased feeding EF decreased Catecolamine, PDE inhibitor Died Myocarditis confirmed by autopsy Questionnaire
8 9 months F Japanese Fever, cough, rhinorrhea, tachypnea 22 200 373 Increased Enlargement of left ventricle, EF decreased ST change Not stated Rapid test Questionnaire
9 10 months M Greek None Low grade fever, cough 70 Sat 90% Not increased Normal, PR Complete heart block IVIG Good Karatza et al9
10 Infant M Japanese Unknown Died Myocarditis confirmed by autopsy Endo and colleagues10
11 1 year F Japanese Kawasaki disease without sequela Fever, cough Infiltration, effusion 9400 700 937 Negative FS 29.6 AV block Catecholamine, PDE blocker, HANP, pacing, ventilation mild decreasing cardiac function Rapid test Questionnaire
12 1 year M Japanese Mild stridor and sudden death Died Myocarditis confirmed by autopsy Goto et al11
13 2 years F Japanese Common cold symptoms 188 EF decreased, ventricular wall thickening VA-ECMO Good Mizuno et al12
14 3 years F Japanese Low birth weight (2150 g) Rhinorrhea, tachypnea, dyspnea Sat 80% Effusion, cardiac enlargement 17 000 4441 2766 Increased EF 9.2%, MR T change Catecolamine, PDE inhibitor Mild decreasing cardiac function Rapid test Questionnaire
15 3 years M Australia Loose cough, vomiting, stridor, fever Increased ESR Wenckebach AV block, ST elevation, flat T wave None Good Menahem and Uren13
16 3 years Unknown None((unknown?)) RS infection at 3 months of age Slow heart rate 30 (bradycardia) None Complete heart block Menehem14
17 4 years F Japanese ALL High fever, tachypnea, tachycardia 180 38 Mild perihilar infiltration 322 (neutrophils) 2.2 0.541 EF 27%, Tei 0.62 ST-T change V4-6 CHF, IVIG, mechanical ventilation Good Type B (serum RNA 1.4 × 108) Miura et al15
18 15 years M USA Syncopy 2 weeks after cough and fever 30 Cardiomegaly, prominence of hilar vessels 8700 128 Complete AV block Temporary pacemaker Prolongation of PR interval Serological diagnosis Giles and Gohd16
19 23 years M USA Dyspnea and chest pain 110 Cardiomegaly, vascular congestion 13 200 Enlargement of left and right ventricle, poor motion of left ventricular posterior wall Nonspecific T change, left atrial enlargement, QRS complexes (left and right ventricle enlargement) Digitalis, diuretics Good Serological diagnosis Giles and Gohd16
20 40 years M African American Fever, chills, dyspnea 130 30 2.2 1.01 EF 10–15% T inversion V4-6 VA-ECMO Good Type A Milas et al17
21 58 years M Japanese Vertigo and fever 2 weeks after common cold symptoms 9000 7+ Complete AV block Pacemaker Pacemaker Serological diagnosis Taira et al18
22 59 years F Japanese Fever and dyspnea 4 weeks after common cold symptoms 9300 3+ PAC, PVC, sinus arrest Diuretics Heart failure Serological diagnosis Taira et al18

Vacant boxes are unwritten information in detail.

Results

The patients were divided into 2 groups by age, that is, 1 group comprised patients younger than 4-years old (16/21 patients: 76.2%) and the other comprised of patients older than 15 years. The latter group mostly developed myocarditis after 2 to 4 weeks after RS infection (Figure 1 and Table 1). Symptoms, excluding those of late-onset cases, were fever (7/13), convulsions (1/13), and cardiopulmonary arrest on arrival (0/13). Laboratory findings were as follows: white blood cell (WBC) count, 7400 to 22 200/μL; C-reactive protein, 0.07 to 3.09 mg/dL; and creatine kinase (CPK), 43 to 373 IU/L. White blood cell counts increased in 9 out of the 11 patients tested. Virus analysis in nasal aspiration was performed and 1 patient each was positive for RSV type B with RNA 1.6 × 109 and RSV type A by RT-LAMP (positive predictive value 94% and negative predictive value 94%).19 ECG displayed disturbance of the conduction system (AV block) in 7 out of 18 patients (38.8%), myocardial damage (ST-T change) in 9 out of 18 patients (50.0%) including both 1 case, and tachycardia in 3 patients (16.6%). Echocardiography showed a substantial decrease in left-heart function in 12 out of 14 patients. Chest X-ray showed normal to mild perihilar infiltration, hyperinflation with perihilar atelectasis, including 2 patients with effusion. Five patients showed cardiomegaly. Supportive therapies, including pacemaker placement were provided. Intravenous immunoglobulin was administered to 4 out of 19 patients. Continuous blood purification (CHF) and extra-corporeal membrane oxygenation (ECMO) were performed in 3 out of 19 patients. The outcome was as follows: 2 fatal, 1 pacemaker placement, 4 patients with mild sequelae, and 1 patient with sequela of motor delay.

Figure 1.

Figure 1.

Age distribution of patients with RSV-associated myocarditis.

Autopsy showed sparse lymphocytes, mild perimyocytic fibrosis, and no cellular necrosis. This patient (number 2 in Table 1) had 1 day of nasal discharge, coughing, and wheezing. On the following day milk intake decreased and no urination was confirmed. She was admitted to hospital because of a positive RSV rapid test. On admission, depressed breathing, tachypnea, no fever, and cold limbs were observed. Chest examination demonstrated expiratory wheezing and decreased breathing sounds. Therefore, administration of neophyllin, and echocardiography was performed. The patient’s ejection fraction was markedly decreased. Under the diagnosis of myocarditis, diuretics, catecholamine, and nitroglycerin were given. Bradycardia and cardiac arrest, as well as cardiopulmonary arrest occurred and death was confirmed without response after 5 hours of admission.

Discussion

Apnea and bradycardia are often associated with RSV infections.20-22 Fetal and lethal arrhythmias, similar to bradyarrhythmia and supraventricular tachycardia owing to myocarditis have been reported to occur in patients with RSV infection.5,7,14,23-25 Goto et al11 found cell infiltration in the myocardium and conduction system on autopsy of a 1-year old boy with asthmatic bronchitis who died suddenly. A systematic review by Eisenhut et al26 showed that extrapulmonary manifestations of RSV infection were cardiovascular failure with hypotension, and inotrope requirement associated with myocardial damage, as evident from increased cardiac troponin levels (35%-54% of ventilated infants), cardiac arrhythmias, such as supraventricular tachycardias and ventricular tachycardias, central apneas, focal and generalized seizures, focal neurological abnormalities, and hepatitis. From those data arrythmia assumed to be caused by invasion of RSV directly or reaction against heart failure by bloodstream infection. Rohwedder et al27 investigated nasal washes and blood samples by using nested reverse transcription and polymerase chain reaction (RT-PCR) and found 6 out of 20 infected cases were positive for RSV-RNA in blood, and concluded that viremia may be a frequent occurrence in neonates and young children.

Myocarditis is defined as the inflammation of cardiac muscle causing myocellular damage leading to cardiac dysfunction and possibly heart failure. Viral infections are considered to be the most common etiology of myocarditis. RSV-associated myocarditis is considered to be a rare cause of viral myocarditis in both the pediatric and adult population. In 12 pediatric and 5 adult patients hospitalized for acute myocarditis, serum samples in the acute phase were positive for viral sequences in 7 (41%) of the 17 myocarditis patients using next-generation sequencing (NGS). Among these patients, RSV reads by NGS were detected in 1 patient.28 Polymerase chain reaction (PCR) identified adenovirus as the most common virus from cardiac samples in the myocardium of children and adults with myocarditis and dilated cardiomyopathy (DCM). RSV was detected in only 1 out of 239 virus-positive patients.29 In the investigation by Akhtar et al30 PCR for the detection of DNA viruses (adenovirus, cytomegalovirus, herpes-simplex virus, and Epstein-Barr virus) and RNA viruses (enterovirus, RSV, and influenza) showed no RSV-positive patients with myocarditis.

On the other hand, previous studies have demonstrated the development of myocardial damage and hepatitis in children with severe RSV infection. Seven (20%) out of 35 ventilated infants with RSV bronchiolitis had an increased right ventricular Tei index indicating reduced right ventricular function. Cardiac troponin T level was increased in 14 patients (41%).31 Esposito studied the frequency of heart involvement in infants with bronchiolitis associated with RSV infection in 69 healthy infants. They reported that sinoatrial blocks were identified in 26/34 RSV-positive patients and 1/35 RSV-negative patients (2.9%). They also found that the sinoatrial (SA) blocks were significantly more frequent in children with an RSV load of ≥100 000 copies/mL than in those with a lower viral load.32

From the results of ECG, RSV-associated myocarditis can be divided into 3 groups referencing Butta’s report.33 The first group is characterized by disturbance of the conduction system. The second group is characterized mainly by myocardial damage. The third group is characterized by excessive autonomy which are considered by tachycardia without severe heart failure (Table 2). The first group showed normal images on echocardiography. Goto et al11 found cell infiltration in the myocardium and conduction system in autopsy samples of a 1-year-old boy with asthmatic bronchitis who died suddenly, and suspected that the direct invasion of viruses causes serious arrhythmia. Therefore, the first group has a high risk for RSV infection.

Table 2.

Classification of Cardiac Pathogenesis on RSV Infection by ECG.

Type 1 Type 2 Type 3
ECG Block pattern ST-T change Tachycardia
Main age All age All age Mainly early infants
Ejection fraction (EF) Normal ↓↓
Progression Rapid Gradually Relative rapid
Correlation of sudden death High Low Low
Outcome Seldom poor Seldom poor Almost good
Suspected pathology Direct viral invasion Myocardial damage Increased autonomy

We have encountered 3 patients with cardiopulmonary arrest caused by RSV infection (manuscript in submission). One patient, who survived after intensive care, showed arrhythmia and was positive for RSV in the cerebrospinal fluid. There have been many reports on the correlation between sudden death and RSV. Williams et al34 investigated the presence of viruses in the respiratory tract of 763 patients who died of sudden infant death during a 9-year period, and showed that 3 out of the 385 (0.8%) patients were younger than 3 months of age and 25 out of the 378 patients (6.6%) were positive for RSV in 1984. Postmortem isolation of RSV from SIDS patients is more common than from non-SIDS infants.35 A recently established sensitive assay that uses real-time PCR also showed similar results. In a study of 403 hospitalized children, sudden death occurred in 7 out of 15 infants who had acute respiratory infections, 6 of which were caused by RSV.36 Parham et al37 proposed that signs of viral infection are usually inconsequential in SIDS infants, because RSV infections are almost universal during infancy and infrequently lead to death, even in hospitalized patients. They concluded that RSV may be a precipitating factor of sudden death.

Finally, rapid diagnostic tests are widely used for the management of RSV-infected patients. However, it was reported that the rapid antigen test had a low sensitivity at 60% and a specificity of 76%.38 Therefore, the incidence of RSV-associated myocarditis might presently be underestimated.

Limitation

Endomyocardial biopsy and positive result for detection of virus are troublesome in patients who have bad condition. This study had limitations because of lacking of tissue biopsy to prove RSV infections in most cases. Therefore heart complication in RSV infection which caused by myocarditis is actual title.

Acknowledgments

We would like to thank Dr. M. Saito (Tsukuba University Hospital), K. Sanayama (Narita Red Cross Hospital), K. Shiga (Teikyo University), and M. Ashiwada (Chiba University Hospital) for their help in collecting the medical records and questionnaire data.

Footnotes

Author Contributions: HK designed the study; NI, SM and TN collected the data; HK wrote the manuscript; and NI, SN, GY and YK provided technical support and conceptual advice. All authors read and approved the final manuscript.

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Funding: The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported in part by a Grant-in-Aid from the Japan Agency for Medical Research and Development (grant number 19fk0108032 and 20fk0108058h0003).

Compliance with Ethical: All procedures performed in studies involving human participants were accordance with the ethical standards of the institutional and national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards (SH3841).

Informed consent was obtained from individual participants by any of the authors.

ORCID iD: Hisashi Kawashima Inline graphic https://orcid.org/0000-0003-2571-9962

References

  • 1.Chi H, Chang IS, Tsai FY, et al. Epidemiological study of hospitalization associated with respiratory syncytial virus infection in Taiwanese children between 2004 and 2007. J Formos Med Assoc. 2011;110:388-396. [DOI] [PubMed] [Google Scholar]
  • 2.Szabo SM, Gooch KL, Bibby MM, et al. The risk of mortality among young children hospitalized for severe respiratory syncytial virus infection. Paediatr Respir Rev. 2013;13 Suppl2:S1-S8. [DOI] [PubMed] [Google Scholar]
  • 3.Mori M, Kawashima H, Nakamura H, et al. Nationwide survey of severe respiratory syncytial virus infection in children who do not meet indications for palivizumab in Japan. J Infect Chemother. 2011;17:254-263. [DOI] [PubMed] [Google Scholar]
  • 4.Kindermann I, Barth C, Mahfoud F, et al. Update on myocarditis. J Am Coll Cardiol. 2012;59:779-792. [DOI] [PubMed] [Google Scholar]
  • 5.Huang M, Bigos D, Levine M.Ventricular arrhythmia associated with respiratory syncytial viral infection. Pediatr Cardiol. 1998;19:498-500. [DOI] [PubMed] [Google Scholar]
  • 6.Araki T, Takahashi N, Nojima I, et al. A case of atrial flutter associated with respiratory syncytial virus. Shounikarinsho. 2012;65:1019-1023. [Google Scholar]
  • 7.Thomas JA, Raroque S, Scott WA, Toro-Figueroa LO, Levin DL.Successful treatment of severe dysrhythmias in infants with respiratory syncytial virus infections. Crit Care Med. 1997;25:880-886. [DOI] [PubMed] [Google Scholar]
  • 8.Menchise A.Myocarditis in the setting of RSV bronchiolitis. Fetal Pediatr Pathol. 2011;30:64-68. [DOI] [PubMed] [Google Scholar]
  • 9.Karatza AA, Kiaffas M, Rammos S.Complete heart block complicating the acute phase of respiratory syncytial virus bronchiolitis. Pediatr Pulmonol. 2017;52:E61-E63. [DOI] [PubMed] [Google Scholar]
  • 10.Ishikawa T, Yuasa I, Endo M.Autopsy of with interstitial pneumonia and myocarditis associated with co-infection. Jpn J Legal Med. 2015;69:164. Japanese. [Google Scholar]
  • 11.Goto Y, Kosuge H, Matsuo S, et al. A 1 year-old boy with sudden death in asthmatic bronchitis due to RS virus infection. Jp J Pediatr Allergy. 2007;21:128. Japanese. [Google Scholar]
  • 12.Mizuno T, Kubota K, Sanami A, et al. A case of fulminant myocarditis cured by E-CPR (extracorporeal cardio-pulmonary resuscitation). J Jpn Society of Emergency Pediatrics. 2016;15:522. Japanese. [Google Scholar]
  • 13.Menahem S, Uren EC.Respiratory syncytial virus and heart block – cause and effect? Aust N Z J Med. 1985;15:55-57. [DOI] [PubMed] [Google Scholar]
  • 14.Menahem S.Respiratory syncytial virus and complete heart block in a child. Cardiol Young. 2010;20:103-104. [DOI] [PubMed] [Google Scholar]
  • 15.Miura H, Hattori F, Uchida H, et al. Case report of severe myocarditis in an immunocompromised child with respiratory syncytial virus infection. BMC Pediatr. 2018;18:51. doi: 10.1186/s12887-018-1027-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Giles TD, Gohd RS.Respiratory syncytial virus and heart disease. A report of two cases. JAMA. 1976;236:1128-1130. [PubMed] [Google Scholar]
  • 17.Milas A, Shah A, Anand N, et al. Respiratory syncytial virus associated myocarditis requiring venoarterial extracorporeal membrane oxygenation. Case Rep Infect Dis. 2017;2017:7074508. doi: 10.1155/2017/7074508 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Taira H, Ohata K, Namiki S, et al. Clinical studies on the five cases of adult myocarditis with severe conduction disturbances on short duration. Shinzo. 1983;15:966-975. Japanese. [Google Scholar]
  • 19.Ushio M, Yui I, Yoshida N, et al. Detection of respiratory syncytial virus genome by subgroups-A, B specific reverse transcription loop-mediated isothermal amplification (RT-LAMP). J Med Virol. 2005;77:121-127. [DOI] [PubMed] [Google Scholar]
  • 20.Anas N, Boettrich C, Hall CB, Brooks JG.The association of apnea and respiratory syncytial virus infection in infants. J Pediatr. 1982;101:65-68. [DOI] [PubMed] [Google Scholar]
  • 21.Bruhn FW, Mokrohisky ST, McIntosh K.Apnea associated with respiratory syncytial virus infection in young infants. J Pediatr. 1977;90:382-386. [DOI] [PubMed] [Google Scholar]
  • 22.Forster J, Schumacher RF.The clinical picture presented by premature neonates infected with the respiratory syncytial virus. Eur J Pediatr. 1995;154:901-905. [DOI] [PubMed] [Google Scholar]
  • 23.Olesch C, Bullock A.Bradyarrhythmia and supraventricular tachycardia in a neonate with RSV. J Paediatr Child Health. 1998;34:199-201. [DOI] [PubMed] [Google Scholar]
  • 24.Playfor SD, Khader A.Arrhythmias associated with respiratory syncytial virus infection. Paediatr Anaesth. 2005;15:1016-1018. [DOI] [PubMed] [Google Scholar]
  • 25.Misirlioğlu ED, Aliefendioğlu D, Alphan N.Supraventricular tachycardia in a neonate with respiratory syncytial virus infection. Anadolu Kardiyol Derg. 2006;6:198. [PubMed] [Google Scholar]
  • 26.Eisenhut M.Extrapulmonary manifestations of severe respiratory syncytial virus infection – a systematic review. Crit Care. 2006;10:R107. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Rohwedder A, Keminer O, Forster J, Schneider K, Schneider E, Werchau H.Detection of respiratory syncytial virus RNA in blood of neonates by polymerase chain reaction. J Med Virol. 1998;54(4):320-327. [DOI] [PubMed] [Google Scholar]
  • 28.Takeuchi S, Kawada JI, Okuno Y, et al. Identification of potential pathogenic viruses in patients with acute myocarditis using next-generation sequencing. J Med Virol. 2018;90:1814-1821. [DOI] [PubMed] [Google Scholar]
  • 29.Bowles NE, Ni J, Kearney DL, et al. Detection of viruses in myocardial tissues by polymerase chain reaction. Evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol. 2003;42:466-472. [DOI] [PubMed] [Google Scholar]
  • 30.Akhtar N, Ni J, Stromberg D, Rosenthal GL, Bowles NE, Towbin JA.Tracheal aspirate as a substrate for polymerase chain reaction detection of viral genome in childhood pneumonia and myocarditis. Circulation. 1999;99:2011-2018. [DOI] [PubMed] [Google Scholar]
  • 31.Thorburn K, Eisenhut M., Shauq A, et al. Right ventricular function in children with severe respiratory syncytial virus (RSV) bronchiolitis. Minerva Anestesiol. 2011;77:46-53. [PubMed] [Google Scholar]
  • 32.Esposito S, Salice P, Bosis S, et al. Altered cardiac rhythm in infants with bronchiolitis and respiratory syncytial virus infection. BMC Infect Dis. 2010;10:305. doi: 10.1186/1471-2334-10-305 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Buttà C, Zappia L, Laterra G, Roberto M.Diagnostic and prognostic role of electrocardiogram in acute myocarditis: a comprehensive review. Ann Noninvasive Electrocardiol. 2020;25:3. doi: 10.1111/anec.12726 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Williams AL, Uren EC, Bretherton L.Respiratory viruses and sudden infant death. Br Med J (Clin Res Ed). 1984;288(6429):1491-1493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Uren EC, Williams AL, Jack I, Rees JW.Association of respiratory virus infections with sudden infant death syndrome. Med J Aust. 1980;1:417-419. [DOI] [PubMed] [Google Scholar]
  • 36.Blanchard B, Barbut P, Bouillie C, Lionsquy G, Seaume H, Gras F.Value of fast indirect immunofluorescence diagnosis of respiratory viruses. Arch Fr Pediatr. 1992;49:93-97. [PubMed] [Google Scholar]
  • 37.Parham DM, Cheng R, Schutze GE, et al. Enzyme-linked immunoassay for respiratory syncytial virus is not predictive of bronchiolitis in sudden infant death syndrome. Pediatr Dev Pathol. 1998;1:375-379. [DOI] [PubMed] [Google Scholar]
  • 38.Myers C, Wagner N, Kaiser L, Posfay-Barbe K, Gervaix A.Use of the rapid antigenic test to determine the duration of isolation in infants hospitalized for respiratory syncytial virus infections. Clin Pediatr (Phila). 2008;47:493-495. [DOI] [PubMed] [Google Scholar]

Articles from Global Pediatric Health are provided here courtesy of SAGE Publications

RESOURCES